RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재후보

      특집-갑상선암의 최신지견 : 갑상선암의 치료 지침 = Special Review : Management guidelines for patients with thyroid cancer

      한글로보기

      https://www.riss.kr/link?id=A76562357

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Incidence of well differentiated thyroid carcinomas (WDTC) has rapidly increased in many countries including Korea recently. Risk stratification of patients with WDTC guides treatment and follow-up strategy of patients, and can classify patients into `very low risk`, `low risk`, `intermediate risk`, and `high risk` of cancer-specific mortality according to characteristics of tumor and of patients. Proper risk stratification requires adequate lymph node dissection and standardized description of pathologic specimen after first surgery for WDTC. Standard treatment modality of WDTC is total or near-total thyroidectomy followed by radioiodine remnant ablation and thyroxine suppression to decrease serum TSH to target levels. `Very low risk` patients can be treated by lobectomy without remnant ablation, and most other patients with WDTC are candidates for `standard treatment`. However, there are controversies in optimal treatment modality for patients with `low risk` and `intermediate risk` patients. Especially, the optimal treatment for patients with micro-PTC (small papillary thyroid cancers) is not known, and it requires more accumulation of data on their clinical course. Management of patients with WDTC who fails to get remission after standard therapy is problematic. Many new chemotherapeutic agents and targeted therapy are under development and some are under evaluation by clinical studies for those patients. (Korean J Med 77:552-558, 2009)
      번역하기

      Incidence of well differentiated thyroid carcinomas (WDTC) has rapidly increased in many countries including Korea recently. Risk stratification of patients with WDTC guides treatment and follow-up strategy of patients, and can classify patients into ...

      Incidence of well differentiated thyroid carcinomas (WDTC) has rapidly increased in many countries including Korea recently. Risk stratification of patients with WDTC guides treatment and follow-up strategy of patients, and can classify patients into `very low risk`, `low risk`, `intermediate risk`, and `high risk` of cancer-specific mortality according to characteristics of tumor and of patients. Proper risk stratification requires adequate lymph node dissection and standardized description of pathologic specimen after first surgery for WDTC. Standard treatment modality of WDTC is total or near-total thyroidectomy followed by radioiodine remnant ablation and thyroxine suppression to decrease serum TSH to target levels. `Very low risk` patients can be treated by lobectomy without remnant ablation, and most other patients with WDTC are candidates for `standard treatment`. However, there are controversies in optimal treatment modality for patients with `low risk` and `intermediate risk` patients. Especially, the optimal treatment for patients with micro-PTC (small papillary thyroid cancers) is not known, and it requires more accumulation of data on their clinical course. Management of patients with WDTC who fails to get remission after standard therapy is problematic. Many new chemotherapeutic agents and targeted therapy are under development and some are under evaluation by clinical studies for those patients. (Korean J Med 77:552-558, 2009)

      더보기

      참고문헌 (Reference)

      1 김원배, "갑상선결절 및 암 진료 권고안" 대한내분비학회 22 (22): 157-187, 2007

      2 National Comprehensive Cancer Network, "Thyroid carcinoma"

      3 Tuttle RM, "Medical management of thyroid cancer: a risk adapted approach" 97 : 712-716, 2008

      4 Cooper DS, "Management guidelines for patients with thyroid nodules and differentiated thyroid cancer" 16 : 109-142, 2006

      5 Davies L, "Increasing incidence of thyroid cancer in the United States, 1973-2002" 295 : 2164-2167, 2006

      6 Leenhardt L, "Increased incidence of thyroid carcinoma in france: a true epidemic or thyroid nodule management effects?: report from the French Thyroid Cancer Committee" 14 : 1056-1060, 2004

      7 British Thyroid Association and Royal College of Physicians, "Guidelines for the management of thyroid cancer in adults" RCP 2002

      8 Pacini F, "European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium" 154 : 787-803, 2006

      9 Korea Central Cancer Registry, "Annual report of the Korean Central Cancer Registry" 2003

      10 Cobin RH, "AACE/AAES medical/surgical guidelines for clinical practice: management of thyroid carcinoma" 7 : 202-220, 2001

      1 김원배, "갑상선결절 및 암 진료 권고안" 대한내분비학회 22 (22): 157-187, 2007

      2 National Comprehensive Cancer Network, "Thyroid carcinoma"

      3 Tuttle RM, "Medical management of thyroid cancer: a risk adapted approach" 97 : 712-716, 2008

      4 Cooper DS, "Management guidelines for patients with thyroid nodules and differentiated thyroid cancer" 16 : 109-142, 2006

      5 Davies L, "Increasing incidence of thyroid cancer in the United States, 1973-2002" 295 : 2164-2167, 2006

      6 Leenhardt L, "Increased incidence of thyroid carcinoma in france: a true epidemic or thyroid nodule management effects?: report from the French Thyroid Cancer Committee" 14 : 1056-1060, 2004

      7 British Thyroid Association and Royal College of Physicians, "Guidelines for the management of thyroid cancer in adults" RCP 2002

      8 Pacini F, "European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium" 154 : 787-803, 2006

      9 Korea Central Cancer Registry, "Annual report of the Korean Central Cancer Registry" 2003

      10 Cobin RH, "AACE/AAES medical/surgical guidelines for clinical practice: management of thyroid carcinoma" 7 : 202-220, 2001

      더보기

      동일학술지(권/호) 다른 논문

      동일학술지 더보기

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2023 평가예정 계속평가 신청대상 (계속평가)
      2021-01-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      2018-12-01 평가 등재후보 탈락 (계속평가)
      2017-12-01 평가 등재후보로 하락 (계속평가) KCI등재후보
      2013-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2010-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2008-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2006-05-15 학술지명변경 외국어명 : Korean Journal of Medicine -> The Korean Journal of Medicine KCI등재
      2006-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2003-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      2002-01-01 평가 등재후보 1차 PASS (등재후보1차) KCI등재후보
      2000-07-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 0.1 0.1 0.1
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.11 0.1 0.259 0.02
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼